Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Sana Biotechnology, Inc. (SANA) had Weighted-Average Shares Outstanding (Diluted) of 230.89M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-266.76M |
|
-- |
|
-- |
|
$272.72M |
|
$-272.72M |
|
$5.96M |
|
$-266.76M |
|
$-266.76M |
|
$-266.76M |
|
$-266.76M |
|
$-266.76M |
|
$-266.76M |
|
$-272.72M |
|
$-255.33M |
|
230.89M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
230.89M |
$-1.16 |
|
$-1.16 |
|
| Balance Sheet Financials | |
$160.81M |
|
$77.31M |
|
$340.21M |
|
$501.02M |
|
$45.43M |
|
-- |
|
$205.08M |
|
$250.52M |
|
$250.50M |
|
$50.68M |
|
$250.50M |
|
223.92M |
|
| Cash Flow Statement Financials | |
$-223.15M |
|
$17.45M |
|
$199.75M |
|
$137.35M |
|
$131.40M |
|
$-5.95M |
|
$37.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-256.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-106.49% |
|
-526.34% |
|
-53.24% |
|
-106.49% |
|
$1.12 |
|
$-1.11 |
|
$-0.97 |
|